IVF (,, ) : (HP-hMG) - (IVF- ET) : GnRH, HP-hMG (HP-hMG )57, (rfsh )140, (Gn)
|
|
- Bertram Page
- 5 years ago
- Views:
Transcription
1 34 11 Vol.34 No Nov Reproduction & Contraception doi: /j.issn X IVF ( ) : (H-hMG) - (IVF- ET) : GnRH H-hMG (H-hMG ) (rfsh ) (Gn) hcg () : ( vs =0.026) H-hMG Gn rfsh hcg rfsh rfsh rfsh rfsh (<0.05) 65.3% 61.7% : rfsh H-hMG : (H-hMG); (rfsh); ; : R711.6 : A : X(2014) IVF (FSH) FSH (LH) FSH ( >10 mm) FSH LH IVF GnRH (GnRH-a) FSH 150 IU FSH LH FSH/LH LH Wely 2003 [1] (hmg) FSH (H-hMG) 75 IU : ; Tel: ; shijuanzi@126.com FSH 10 IU hcg hcg LH α LH 1 IU hcg 6~7 IU LH 31 h LH 13 h hcg LH LH [2] FSH(rFSH) H-hMG ~ IVF : 38 ; GnRH-a ; HhMG(H-hMG ) rfsh(rfsh ) : (EMs) ; 892
2 (AFC) ( ): AFC>8 0.1 mg/d AFC mg/d 14 d Gn 0.05 mg/d : FSH 5 IU/L; LH 5 IU/L; E2 50 pg/ml; 5 mm; 5 mm 1.3 Gn H-hMG H-hMG( )150~225 IU/d rfsh rfsh( )150~225 IU/d 5 Gn <10 mm E2<300 pg/ml Gn hcg 1.4 hcg >17 mm >14 mm 60% (rhcg )250 μg 36 h IVF >20 B ~14 d β-hcg β-hcg 5 IU/L 35 d B (<0.01) rfsh (<0.05) rfsh (<0.01) (>0.05) (>0.05) rfsh (x s) Table 1 Comparison of the patients baseline characteristics between two groups Index H-hMG group rfsh group (n) No. of cycles ( ) Age (year) (24~38) (21~37) ( ) Infertility duration (a) (1~10) (0.5~12) BMI (kg/m 2 ) FSH Basal FSH (miu/ml) AFC (n) COS 21.1 (12/) 27.9 (39/) Incidence of COS (%) 1.6 SSS16.0 (x s) (%) t χ 2 < FSH (>0.05) rfsh 2.2 COS H-hMG 1 H-hMG Gn rfsh (<0.01) hcg 2 (x s) Table 2 Comparison of the patients ovarian stimulation characteristics between two groups Index H-hMG group rfsh group n Gn <0.001 Total dosage of Gn (IU) <0.001 Duration of Gn used (d) hcg Day of hcg injection E E2 peak (pg/ml) (ng/ml) LH (IU)
3 () (x s) Table 3 The patients clinical outcomes Index H-hMG group rfsh group n 14.0 (8/) 40.0 (56/) / Rate of cancellation cycles (%) 14.0 (8/) 35.0 (49/) Cancellation rate due to (%) hcg 14 mm No. of follicles with diameter size 14 mm on hcg injection day <0.001 No. of oocyte retrieval (n) Endometrial thickness (mm) Embryo transfer number (n) 75.0 (5/743) 77.3 (1 922/2 487) Fertilization rate (%) 69.9 (355/508) 61.2 (1 151/1 881) <0.001 Embryo available rate (%) 39.8 (27/48) Implantation rate (%) 65.3 (32/49) 42.3 (60/142) 60.7 (51/84) / Clinical pregnancy rate per embryo transfer cycle (%) 3 LH >10 mm FSH / [1] (LH/CG ) 5 mm LH GnRH FSH LH [2] FSH LH [3] Balasch LH [4] LH 2008 O Dea [5] LH<1.2 IU/L LH LH>1.2 IU/L FSH LH E2 FSH LH (ART) [67] H-hMG Gn H-hMG COS H-hMG Gn LH LH LH FSH hcg E2 [8] H-hMG H-hMG rfsh [9] AFC H-hMG 6 d 1~2 AFC>5 Gn E2 Gn HhMG rfsh Gn 6 H-hMG FSH LH ~2 1 rfsh? AFC H-hMG [8] H-hMG rfsh rfsh (69.9% vs 61.2%) Meta [10] hmg(uhmg) (COH) LH FSH 894
4 [9] hcg H-hMG E2 820 pmol/l rfsh 663 mmol/l rfsh [11] ART LH [12] H-hMG hcg : ; 1 (insulin-like growth factor-binding protein-1 IGFB- 1) (vascular endothelial growth factor VEGF) [1314] rfsh hcg H-hMG [1516] H-hCG rfsh H-hMG IVF rfsh H-hMG hcg E2 AFC rfsh ; AFC COS H-hMG [1] Jeppesen JV Kristensen SG Niesen ME et al. LH-receptor gene expression in human granulosa and cumulus cells from antral and preovulatory follicles. JCEM (8): e [2] Balasch J Fábregues F Casamitjana R et al. A pharmacokinetic and endocrine comparison of recombinant follicle-stimulating hormone and human menopausal gonadotrophin in polycystic ovary syndrome. Reprod Biomed Online (3): [3] Ferrell RJ O Connor KA Holman DJ et al. Monitoring reproductive aging in a 5-year prospective study: aggregate and individual changes in luteinizing hormone and follicle stimulating hormone with age. Menopause (1): [4] Balasch J Fabregues F. Is luteinizing hormone needed for optimal ovulation induction? Curr Opin Obstet Gynecol (3): [5] O Dea L O Brien F Currie K et al. Follicular development induced by recombinant luteinizing hormone (LH) and follicle stimulating hormone (FSH) in anovulatory women with LH and FSH deficiency: evidence of a threshold effect. Curr Med Res Opin (10): [6] Van Wely M Kwan I Burt AL. Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles. A Cochrane review. Hum Reprod Update (2):111. [7] Andersen AN Devroey Arce JC. Clinical outcome following stimulation with highly purified hmg or recombinant FSH in patients undergoing IVF: a randomized assessorblind controlled trial. Hum Reprod (12): [8] Figen TA Seckin B Onalan G. Human menopausal gonadotropin versus recombinant FSH in polycystic ovary syndrome patients undergoing in vitro fertilization. Int J Fertil Steril (4): [9] Hompes G Broekmans FJ Hoozemans DA. Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization intracytoplasmic sperm injection patients. Fertil Steril (6): [10] Arri C Masoud A Deepti C et al. Urinary hmg verse recombinant FSH for controlled ovarian hyperstimulation following an agonist long down-regulation protocol in IVF or ICSI treatment: a systematic review and mete-analysis. Hum Reprod (2): [11] AndreaW Santigo M Werner B et al. The impact of LH containing gonadotropins on diploid rates in preimplantation embryos: long protocol stimulation. Hum Reprod (3): [12] McGee EA Hsueh AJ. Initial and cyclic recruitment of ovarian follicles. Endocr Rev (2): [13] Filicori M Fazleabas AT Huhtaniemi I et al. Novel concepts of human chorionic gonadotropin: reproductive system interactions and potential in the management of infertility. Fertil Steril (2):
5 [14] Durnerin G Erb K Fleming R et al. Effects of recombinant LH treatment on folliculogenesis and responsiveness to FSH stimulation. Hum Reprod (2): [15] latteau Nyboe Andersen A Loft A et al. Highly purified hmg versus recombinant FSH for ovarian stimulation in IVF cycles. Reprod Biomed Online (2): [16] Ziebe S Lundin K Janssens R et al. Influence of ovarian stimulation with H-hMG or recombinant FSH on embryo quality parameters in patients undergoing IVF. Hum Reprod (9): ( ) reliminary Exploration of Comparing High urified hmg with rfsh in Controlled Ovarian Hyperstimulation of IVF Cycles Li TIAN Na LI Juan-zi SHI Hai-yan BAI (Center for Assisted Reproduction Technology Maternal & Child Health Care Hospital of Shanxi rovince Xi an ) ABSTRACT Objective: To evaluate the efficacy of highly purified human menopausal gonadotrophin (HhMG) in patients with normal ovarian reservation in controlled ovarian hyperstimulation (COH) during IVF cycles. Methods: A retrospective study was carried out in our IVF center. Those patients with normal ovarian reservation who were planned to undergo GnRH-a long protocol treatment were enrolled in this study. Totally patients were performed in H-hMG group and patients were performed in recombinant FSH (rfsh) group. The main observational outcomes included total dosage of Gn duration of ovarian stimulation the number of oocyte retrieved implantation rate clinical pregnancy rate serum estradiol (E2) level and progesterone () level on hcg injection day and cancellation rate due to ovarian hyperstimulation syndrome () risk. Results: Compared with rfsh patients in H-hMG group was older ( years vs years =0.026). Total Gn dosage was higher in H-hM group than in rfsh group. Also in H-hMG group patients need more time for total stimulation duration. On the day of hcg injection serum E2 and levels were lower in H-hMG group. The number of oocyte retrieved was less in H-hMG group but in this group patients had higher embryo available rate than that in rfsh group. H-hMG group experienced lower cancellation rate to prevent. Though higher clinical pregnancy rate showed in H-hMG group (65.3% vs 61.7%) there was no significantly statistic difference between the two groups. Conclusion: Compared with rfsh H-hMG needs higher dosage or longer duration for ovary stimulation but has lower risk higher available embryo rate and a tendency of higher clinical pregnancy rates. Key words: highly purified human menopausal gonadotrophin (H-hMG); recombinant FSH (rfsh); ovarian hyperstimulation; clinical pregnancy rate 896
(BMI)=18.0~24.9 kg/m 2 ;
33 10 Vol.33 No.10 2013 10 Oct. 2013 Reproduction & Contraception doi: 10.7669/j.issn.0253-357X.2013.10.0672 E-mail: randc_journal@163.com - ( 400013) : () GnRH-a - () : IVF- ET 233 A (I~II 102 ) B (III~IV
More information(1.,, ) (2.,,, )
33 11 Vol.33 No.11 2013 11 Nov. 2013 Reproduction & Contraception doi: 10.7669/j.issn.0253-357X.2013.11.0749 E-mail: randc_journal@163.com IVF-ET 1 2 1 1 1 1 1 (1. 510150) (2. 510150) : (COH) (premature
More informationA Tale of Three Hormones: hcg, Progesterone and AMH
A Tale of Three Hormones: hcg, Progesterone and AMH Download the Ferring AR ipad/iphone app from the Apple Store: http://bit.ly/1okk74m Human Ovarian Steroidogenesis and Gonadotrophin Stimulation Johan
More information- Meta. : (rfsh); (ufsh); (IVF); : R711.6 : A : X(2015) : hmg( FSH LH) [ufsh, (ufsh-p) (ufsh-hp)] (rfsh) [1] 80, rfsh, 90, :
35 2 Vol.35 No.2 2015 2 Feb. 2015 Reproduction & Contraception doi: 10.7669/j.issn.0253-357X.2015.02.0099 E-mail: randc_journal@163.com (FSH) - Meta FSH ( 400010) : (IVF) (ICSI) (rfsh) (ufsh) (COS) : PubMed
More informationA Tale of Three Hormones: hcg, Progesterone and AMH
A Tale of Three Hormones: hcg, Progesterone and AMH Download the Ferring AR ipad/iphone app from the Apple Store: http://bit.ly/1okk74m Interpreting Follicular Phase Progesterone Ernesto Bosch IVI Valencia,
More informationThe impact of HMG on follicular fluid hormone levels, embryo quality and IVF outcome
Eastern Journal of Medicine 19 (2014) 22-27 Original Article The impact of HMG on follicular fluid hormone levels, embryo quality and IVF outcome Gokce Anik Ilhan a,*, Gozde Erkanli Senturk a, Ozgur Oktem
More informationHighly purified hmg versus recombinant FSH in ovarian hyperstimulation with GnRH antagonists a randomized study
Human Reproduction Vol.23, No.10 pp. 2346 2351, 2008 Advance Access publication on June 25, 2008 doi:10.1093/humrep/den220 Highly purified hmg versus recombinant FSH in ovarian hyperstimulation with GnRH
More informationLuteal phase rescue after GnRHa triggering Progesterone and Estradiol
Luteal phase rescue after GnRHa triggering Progesterone and Estradiol L. Engmann University of Connecticut Disclaimer Fertility Speaker Bureau Merck Pharmaceuticals Introduction GnRH agonist is effective
More information2015 Mar.; 26(1):
Journal of Reproduction & Contraception doi: 10.7669/j.issn.1001-7844.2015.01.0022 2015 Mar.; 26(1):22-30 E-mail: randc_journal@163.com Clinical outcomes of using three gonadatropins and medroxyprogestrone
More informationInterpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used
Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used Ellenbogen A., M.D., Shalom-Paz E., M.D, Asalih N., M.D, Samara
More informationIntérêt de l hcg et induction de l ovulation. Christophe Blockeel, MD, PhD Centre for Reproductive Medicine, Brussels, Belgium
Intérêt de l hcg et induction de l ovulation Christophe Blockeel, MD, PhD Centre for Reproductive Medicine, Brussels, Belgium Conflict of interest The opinions expressed in this document are the opinions
More informationBest practices of ASRM and ESHRE
Best practices of ASRM and ESHRE Late submission Cortina d Ampezzo, Italy 1-3 March 2012 A joint meeting between the American Society for Reproductive Medicine and the European Society of Human Reproduction
More informationRaoul Orvieto. The Chaim Sheba Medical Center Tel Hashomer, Israel. Declared no potential conflict of interest
Raoul Orvieto The Chaim Sheba Medical Center Tel Hashomer, Israel Declared no potential conflict of interest LH in antagonist cycles; is the story really written? Raoul Orvieto M.D. Israel Overview Role
More informationlbt lab tests t Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour
lbt lab tests t and Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour Research Instituteof Avicenna 4/23/2012 Why good prediction of poor response good prediction i of OHSS application appropriate
More informationAdvanced age, poor responders and the role of LH supplementation. C. Alviggi University Federico II, Naples, Italy
Advanced age, poor responders and the role of LH supplementation C. Alviggi University Federico II, Naples, Italy LH serum level (IU/L) 20.0 15.0 10.0 5.0 0.0 LH levels during spontaneous and stimulated
More informationPersonalizing ovarian stimulation for IVF
Personalizing ovarian stimulation for IVF Biljana Popovic-Todorovic MD,PhD Centre for Reproductive Medicine UZ Brussel QuickTime and are needed to see this picture. Controlled ovarian stimulation for IVF/ICSI
More informationClinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin in Normogonadotropic Infertile Patients
International Reproductive Medicine Volume 2013, Article ID 135258, 4 pages http://dx.doi.org/10.1155/2013/135258 Clinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin
More informationNeil Goodman, MD, FACE
Initial Workup of Infertile Couple: Female Neil Goodman, MD, FACE Professor of Medicine Voluntary Faculty University of Miami Miller School of Medicine Scope of Infertility in the United States Affects
More informationDr. Ernesto Bosch Instituto Valenciano de Infertilidad Valencia, Spain. Declared no potential conflict of interest
Dr. Ernesto Bosch Instituto Valenciano de Infertilidad Valencia, Spain Declared no potential conflict of interest Is there a role for LH in elderly patients? Dr. Ernesto Bosch Instituto Valenciano de Infertilidad.
More informationFactors influencing serum progesterone level on triggering day in stimulated in vitro fertilization cycles
ORIGINAL ARTICLE pissn 2233-8233 eissn 2233-8241 Clin Exp Reprod Med 2015;42(2):67-71 Factors influencing serum progesterone level on triggering day in stimulated in vitro fertilization cycles Ju Hee Park
More informationEffects of HCG and LH on ovarian stimulation. Are they bioequivalent?
Effects of HCG and LH on ovarian stimulation Are they bioequivalent? Know the type of gonadotrophin required to have enough oocytes of good quality to achieve a healthy child FSH MAXIMIZE EFFICIENCY MINIMIZE
More information2013 Sep.; 24(3):
Journal of Reproduction & Contraception doi: 10.7669/j.issn.1001-7844.2013.03.0151 2013 Sep.; 24(3):151-158 E-mail: randc_journal@163.com Reducing the Trigger Dose of Human Chorionic Gonadotrophin Does
More informationLiyan Duan 1, Shihua Bao 1, Kunming Li 1, Xiaoming Teng 1, Ling Hong 1 and Xiaoyu Zhao 2. Abstract. Introduction
doi:10.1111/jog.13305 J. Obstet. Gynaecol. Res. Vol. 43, No. 6: 1037 1042, June 2017 Comparing the long-acting and short-acting forms of gonadotropin-releasing hormone agonists in the long protocol of
More informationThe emergence of Personalized Medicine protocols for IVF.
Individualising IVF: Introduction to the POSEIDON Concept Introduction The emergence of Personalized Medicine protocols for IVF. Differences between patients: age, ovarian reserve, BMI or presence of ovarian
More informationRelevance of LH activity supplementation
Relevance of LH activity supplementation in ovulation induction Franco Lisi Servizio di Fisiopatologia della Riproduzione Clinica Villa Europa Roma, Italia Comprehension of the role of LH in follicular
More informationManish Banker. Declared receipt of grants; member of a company advisory board, board of director or similar group
Manish Banker Nova IVI Fertility Pulse Women's Hospital Gujarat, India Declared receipt of grants; member of a company advisory board, board of director or similar group The Indian point of view Manish
More informationRafael A. Cabrera, M.D., Laurel Stadtmauer, M.D., Ph.D., Jacob F. Mayer, Ph.D., William E. Gibbons, M.D., and Sergio Oehninger, M.D., Ph.D.
Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing hormone agonist and stimulated with recombinant
More informationDoes previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation treatment cycles?
J Assist Reprod Genet (26) 23:427 431 DOI 1.17/s1815-6-965-x ASSISTED REPRODUCTION Does previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation
More informationR-Recent Advance in Patient Friendly Protocol
R-Recent Advance in Patient Friendly Protocol Somjate Manipalviratn, M.D. Reproductive Endocrinologist and Infertility Specialist Clinical Director Superior A.R.T., Bangkok, Thailand Objective of ovarian
More informationOriginal Article Impact of estrogen-to-oocyte ratio on live birth rate in women undergoing in vitro fertilization and embryo transfer
Int J Clin Exp Med 2015;8(7):11327-11331 www.ijcem.com /ISSN:1940-5901/IJCEM0008838 Original Article Impact of estrogen-to-oocyte ratio on live birth rate in women undergoing in vitro fertilization and
More informationEvaluation of ovarian response prediction according to age and serum AMH levels in IVF cycles: a retrospective analysis
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Pillai SM et al. Int J Reprod Contracept Obstet Gynecol. 2017 Aug;6(8):3306-3310 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20173190
More informationPremature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles
Arch Gynecol Obstet (2010) 281:747 752 DOI 10.1007/s00404-009-1248-0 REPRODUCTIVE MEDICINE Premature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles Esra
More informationTreatment of Poor Responders
Treatment of Poor Responders Pathophysiology of Poor Responders Deficiency in systemic IGF 1 levels (Bahceci, 2007) Lower intra ovarian T levels Reduced FSH receptor expression (Cai, 2007) Bahceci, 2007,
More informationDoes triggering ovulation by 5000 IU of uhcg affect ICSI outcome? *
Middle East Fertility Society Journal Vol. 11, No. 2, 2006 Copyright Middle East Fertility Society Does triggering ovulation by 5000 IU of uhcg affect ICSI outcome? * Amany A.M. Shaltout, M.D. Mohamed
More informationComparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization
Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization Peter Kovacs, M.D., a Timea Kovats, M.D., a Artur Bernard,
More information1 (gonadotropin, Gn) -,, : - (IVF-ET); (COH); ; : R711.6 : A : X(2014)
34 10 Vol.34 No.10 2014 10 Oct. 2014 Reproduction & Contraception doi: 10.7669/j.issn.0253-357X.2014.10.0858 E-mail: randc_journal@163.com ( 200001) - : - (IVF-ET); (COH); ; : R711.6 : A : 0253-357X(2014)10-0858-07
More informationPoor & Hyper responders: what is the best approach?
Poor & Hyper responders: what is the best approach? A. La Marca ObGyn Dept University of Modena and Reggio Emilia Italy Center for Reproductive Medicine University Hospital of Modena Italy Criteria used
More information% Oocyte Donation Pregnancyes (days 3)
Ovulation induction in oocyte donors Roma- September 2007 Dr. José Remohí Dr. Carmen Rubio Dr. Amparo Mercader Dr. Pilar Alama Dr. Marco Melo Evolution of oocyte donation cycles 1500 1500 1000 58% 661
More information2013 Sep.; 24(3):
Journal of Reproduction & Contraception doi: 10.7669/j.issn.1001-7844.2013.03.0159 2013 Sep.; 24(3):159-172 E-mail: randc_journal@163.com Comparison of the Effects and Safety of Mild Ovarian Stimulation
More informationPrognosticating ovarian reserve by the new ovarian response prediction index
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Tak A et al. Int J Reprod Contracept Obstet Gynecol. 2018 Mar;7(3):1196-1200 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20180917
More informationInfertility Clinical Guideline
Infertility Clinical Guideline Ovarian Stimulation Guideline Purpose: To provide sufficient background regarding various ovarian stimulation protocols for In Vitro Fertilization cycles. Goal: To assist
More informationA Case of Pregnancy Using Recombinant Follicle Stimulating Hormone and Gonadotropin Releasing Hormone Antagonist
1 *, ** * * * ** A Case of Pregnancy Using Recombinant Follicle Stimulating Hormone and Gonadotropin Releasing Hormone Antagonist Yoon Sung Nam, Nam Keun Kim*, Eun Kyung Kim**, Hyung Min Chung** and Kwang
More informationWhich is the Best Protocol of Ovarian Stimulation Prior to Artificial Insemination by Donor
Journal of Reproduction & Contraception doi: 10.7669j.issn.1001-7844.2014.01.0041 2014 Mar.; 25(1):41-48 E-mail: randc_journal@163.com Which is the Best Protocol of Ovarian Stimulation Prior to Artificial
More informationAgonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M
Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M Record Status This is a critical abstract of an economic
More informationCorifollitropin alfa or rfsh treatment flexibility options for controlled ovarian stimulation: a post hoc analysis of the Engage trial
Leader et al. Reproductive Biology and Endocrinology 2013, 11:52 RESEARCH Open Access Corifollitropin alfa or rfsh treatment flexibility options for controlled ovarian stimulation: a post hoc analysis
More informationSTIMULATION AND OVULATION TRIGGERING
STIMULATION AND OVULATION TRIGGERING Professor IOANNIS E. MESSINIS MD, PhD (Aberdeen, UK), FRCOG (UK) Department of Obs/Gynae University of Thessaly Larissa, GREECE DISCLOSURE Nothing to disclose Learning
More informationInternational Journal of Women s Health and Reproduction Sciences Vol. 6, No. 2, April 2018, ISSN
http://www.ijwhr.net Open Access doi 10.15296/ijwhr.2018.31 Original Article International Journal of Women s Health and Reproduction Sciences Vol. 6, No. 2, April 2018, 187 191 ISSN 2330-4456 Comparison
More informationAre all-freeze cycles & frozen-thawed embryo transfers improving IVF outcomes?
Are all-freeze cycles & frozen-thawed embryo transfers improving IVF outcomes? Andrea Weghofer Foundation for Reproductive Medicine 2017 New York, November 16-19 Conflict of interest No relevant financial
More informationThe serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins
Original Article Obstet Gynecol Sci 2018;61(2):242-246 https://doi.org/10.5468/ogs.2018.61.2.242 pissn 2287-8572 eissn 2287-8580 The serum estradiol/oocyte ratio in patients with breast cancer undergoing
More informationCOMPARING AMH, AFC AND FSH FOR PREDICTING HIGH OVARIAN RESPONSE IN WOMEN UNDERGOING ANTAGONIST PROTOCOL
COMPARING AMH, AFC AND FSH FOR PREDICTING HIGH OVARIAN RESPONSE IN WOMEN UNDERGOING ANTAGONIST PROTOCOL Nguyen Xuan Hoi1, Nguyen Manh Ha2 1 National Obstetrics and Gynecology Hospital, 2Hanoi Medical Unviversity
More informationFemale Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF
Female Reproductive Physiology Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF REFERENCE Lew, R, Natural History of ovarian function including assessment of ovarian reserve
More informationMenstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists
Human Reproduction Vol.21, No.4 pp. 1012 1017, 2006 Advance Access publication December 8, 2005. doi:10.1093/humrep/dei415 Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists
More informationFERTILITY PRESERVATION IN BREAST CANCER PATIENTS: FOLLICULAR BIOMARKERS IN LETROZOLE ASSOCIATED OVARIAN HYPERSTIMULATION
FERTILITY PRESERVATION IN BREAST CANCER PATIENTS: FOLLICULAR BIOMARKERS IN LETROZOLE ASSOCIATED OVARIAN HYPERSTIMULATION Ornit GOLDRAT Research Laboratory in Human Reproduction, Fertility Clinic, Department
More informationIs it the seed or the soil? Arthur Leader, MD, FRCSC
The Physiological Limits of Ovarian Stimulation Is it the seed or the soil? Arthur Leader, MD, FRCSC Objectives 1. To consider how ovarian stimulation protocols work in IVF 2. To review the key events
More informationProgesterone and clinical outcomes
Synchronization of Slowly Developing Embryos Restores Implantation Success Richard T. Scott, Jr, MD, HCLD Clinical and Scientific Director, Reproductive Medicine Associates of New Jersey Professor and
More informationENDOCRINE CHARACTERISTICS OF ART CYCLES
ENDOCRINE CHARACTERISTICS OF ART CYCLES DOÇ. DR. SEBİHA ÖZDEMİR ÖZKAN KOCAELI UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF OBSTETRICS AND GYNECOLOGY, IVF UNIT 30.04.2014, ANTALYA INTRODUCTION The endocrine
More informationOutcomes after early or midfollicular phase LH supplementation in previous inadequate responders
Reproductive BioMedicine Online (2010) 20, 350 357 www.sciencedirect.com www.rbmonline.com ARTICLE Outcomes after early or midfollicular phase LH supplementation in previous inadequate responders MSönmezer
More informationCommon protocols in intra-uterine insemination cycles
Common protocols in intra-uterine insemination cycles Doç. Dr. Candan İltemir Duvan Turgut Özal Üniversitesi Tıp Fakültesi Kadın Hastalıkları ve Doğum AD Ovulation induction with intra-uterine insemination
More informationArticle Highly purified HMG versus recombinant FSH for ovarian stimulation in IVF cycles
RBMOnline - Vol 17. No 2. 2008 190-198 Reproductive BioMedicine Online; www.rbmonline.com/article/3332 on web 19 June 2008 Article Highly purified HMG versus recombinant FSH for ovarian stimulation in
More informationA prospective randomised study comparing a GnRH-antagonist versus a GnRH-agonist short protocol for ovarian stimulation in patients referred for IVF
FVV IN OBGYN, 2012, 4 (2): 82-87 Original paper A prospective randomised study comparing a GnRH-antagonist versus a GnRH-agonist short protocol for ovarian stimulation in patients referred for IVF S. GORDTS,
More informationPredictive factors for ovarian response in a corifollitropin alfa/gnrh antagonist protocol for controlled ovarian stimulation in IVF/ICSI cycles
Oehninger et al. Reproductive Biology and Endocrinology (2015) 13:117 DOI 10.1186/s12958-015-0113-1 RESEARCH Open Access Predictive factors for ovarian response in a corifollitropin alfa/gnrh antagonist
More information2017 United HealthCare Services, Inc.
UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 1143-4 Program Prior Authorization/Notification Medication Menopur (menotropins) * P&T Approval Date 8/2014, 5/2015, 5/2016, 5/2017
More informationLH activity administration during the
LH activity administration during the luteal-follicular transition Richard Fleming On behalf of the Luveris Pre-treatment group University of Glasgow Scotland Androgens have a Paracrine action in the Early
More informationInfluence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser
Influence ovarian stimulation on oocyte and embryo quality Prof.Dr. Bart CJM Fauser How to balance too much vs too little? Lecture Outline Context ovarian stimulation Impact ovarian stimulation on oocyte
More informationMahnaz Ashrafi Kiandokht Kiani Afsaneh Ghasemi Fatemeh Rastegar Maryam Nabavi
DOI 10.1007/s00404-010-1827-0 GENERAL GYNECOLOGY The effect of low dose human chorionic gonadotropin on follicular response and oocyte maturation in PCOS patients undergoing IVF cycles: a randomized clinical
More informationEHY Ng, WSB Yeung, PC Ho. Introduction
Comparison of two dosages of recombinant human follicle-stimulating hormone in Chinese women undergoing controlled ovarian stimulation: prospective randomised double-blind study EHY Ng, WSB Yeung, PC Ho
More informationLUTEAL PHASE SUPPORT. Doç. Dr. Nafiye Yılmaz. Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi
LUTEAL PHASE SUPPORT Doç. Dr. Nafiye Yılmaz Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi TAJEV, 2014 1 ART & success *Live birth rate 2 Optimal luteal phase Etiology of luteal phase deficiency
More informationIVF Protocols: Hyper & Hypo-Responders, Implantation
IVF Protocols: Hyper & Hypo-Responders, Implantation Midwest Reproductive Symposium June 4-5, 4 2010 Subset : Hyper-Responders Mark R. Bush, MD, FACOG, FACS OBJECTIVE: Important goals for the PCOS patient
More informationOriginal Article Effects of a low hcg dose of 2000 IU on clinical outcomes of high-responder women undergoing IVF/ICSI
Int J Clin Exp Med 2016;9(7):14677-14683 www.ijcem.com /ISSN:1940-5901/IJCEM0026636 Original Article Effects of a low hcg dose of 2000 IU on clinical outcomes of high-responder women undergoing IVF/ICSI
More informationSredišnja medicinska knjižnica
Središnja medicinska knjižnica Kasum M., Kurdija K., Orešković S., Čehić E., Pavičić-Baldani D., Škrgatić L. (2016) Combined ovulation triggering with GnRH agonist and hcg in IVF patients. Gynecological
More informationAMH CUT-OFF VALUES FOR PREDICTING OVARIAN RESPONSE IN IVF. Nguyễn Xuân Hợi, MD, PhD Hoàng Văn Hùng MsC, MD
AMH CUT-OFF VALUES FOR PREDICTING OVARIAN RESPONSE IN IVF Nguyễn Xuân Hợi, MD, PhD Hoàng Văn Hùng MsC, MD INTRODUCTION Ovarian stimulation is an important process in IVF treatment, aiming at obtain a number
More informationElonva (corifollitropin alfa): A simplified, patientfocused
Product Monograph (corifollitropin alfa): A simplified, patientfocused approach to controlled ovarian stimulation TABLE OF CONTENTS (corifollitropin alfa): A simplified, patientfocused approach to controlled
More informationFollicle-stimulating hormone/luteinizing hormone ratio as an independent predictor of response to controlled ovarian stimulation
Follicle-stimulating hormone/luteinizing hormone ratio as an independent predictor of response to controlled ovarian stimulation Aim: To determine whether a follicle-stimulating hormone (FSH)/luteinizing
More informationA multi-centre, multinational, cross-sectional, incident case control study on Factors associated with the development of
A multi-centre, multinational, cross-sectional, incident case control study on Factors associated with the development of Endometrioma and deep infiltrating endometriosis Professor C. Chapron and the Group
More informationProgesterone vaginal capsule versus vaginal gel for luteal support in normoresponder women undergoing long agonist IVF/ICSI cycles
ORIGINAL PAPER / OBSTETRICS Ginekologia Polska 2016, vol. 87, no. 5, 372 377 Copyright 2016 Via Medica ISSN 0017 0011 DOI: 10.5603/GP.2016.0007 Progesterone vaginal capsule versus vaginal gel for luteal
More informationI. ART PROCEDURES. A. In Vitro Fertilization (IVF)
DFW Fertility Associates ASSISTED REPRODUCTIVE TECHNOLOGY (ART) Welcome to DFW Fertility Associates/ Presbyterian-Harris Methodist Hospital ARTS program. This document provides an overview of treatment
More informationClinical consequences of ovarian stimulation in assisted conception and in PCOS Al-Inany, H.G.
UvA-DARE (Digital Academic Repository) Clinical consequences of ovarian stimulation in assisted conception and in PCOS Al-Inany, H.G. Link to publication Citation for published version (APA): Al-Inany,
More informationSerum progesterone levels on the day of hcg trigger and ICSI outcome: a retrospective observational cohort study
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Amin KV et al. Int J Reprod Contracept Obstet Gynecol. 2018 Aug;7(8):3194-3198 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20183316
More informationChen et al. Reproductive Biology and Endocrinology (2018) 16:36 https://doi.org/ /s z
Chen et al. Reproductive Biology and Endocrinology (2018) 16:36 https://doi.org/10.1186/s12958-018-0352-z RESEARCH Open Access Pregnancy outcomes of PCOS overweight/ obese patients after controlled ovarian
More informationLOW RESPONDERS. Poor Ovarian Response, Por
LOW RESPONDERS Poor Ovarian Response, Por Patients with a low number of retrieved oocytes despite adequate ovarian stimulation during fertility treatment. Diagnosis Female About Low responders In patients
More informationEndometrial Preparation for Frozen Embryo Transfer (FET) Zitao Liu, MD, PhD New Hope Fertility Center, NY
Endometrial Preparation for Frozen Embryo Transfer (FET) Zitao Liu, MD, PhD New Hope Fertility Center, NY Natural Cycle FET Protocol for endometrial preparation N FET, including modified N FET HRT FET:
More informationPredictive factors for oocyte retrieval failure in controlled ovarian hyperstimulation protocols: a retrospective observational cohort study
Hasegawa et al. Reproductive Biology and Endocrinology (2015) 13:53 DOI 10.1186/s12958-015-0052-x RESEARCH Open Access Predictive factors for oocyte retrieval failure in controlled ovarian hyperstimulation
More informationAddition of low dose hcg to rfsh benefits older women during ovarian stimulation for IVF
Gomaa et al. Reproductive Biology and Endocrinology 2012, 10:55 RESEARCH Open Access Addition of low dose hcg to rfsh benefits older women during ovarian stimulation for IVF Hala Gomaa 1,2,3, Robert F
More informationFixed Schedule for in vitro Fertilization and Embryo Transfer: Comparison of Outcome between the Short and the Long Protocol
Yamanashi Med. J. 14(3), 77 ~ 82, 1999 Original Article Fixed Schedule for in vitro Fertilization and Embryo Transfer: Comparison of Outcome between the Short and the Long Protocol Tsuyoshi KASAI and Kazuhiko
More informationUniversity Hospital Dr. Peset, Valencia, Spain
A prospective, randomized, controlled trial comparing three different gonadotropin regimens in oocyte donors: ovarian response, in vitro fertilization outcome, and analysis of cost minimization Marco Melo,
More informationNo association between endogenous LH and pregnancy in a GnRH antagonist protocol: part II, recombinant FSH
Reproductive BioMedicine Online (2011) 23, 457 465 www.sciencedirect.com www.rbmonline.com ARTICLE No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part II, recombinant
More informationIranian Journal of Reproductive Medicine Vol. 2. No.1 pp 29-33, 2004
Efficacy of Low Dose, Long-acting Gonadotropin Releasing Hormone Analogues (GnRH-a) Compared with Daily Injections of Short-acting GnRH-a in ART Cycles Robabeh Taheripanah M.D. 1, Mohammad A. Karimzadeh
More information(Predictive. value) Soheila Ansaripour Fellowship of infertility Ai Avicena Research In
Ovarian Rese erve Lab Tests In (Predictive IVF value) Soheila Ansaripour Fellowship of infertility Ai Avicena Research In nstitute t Case Presentation 29 y/o,primary inf 1.5yr, Hx of irregular menses (
More informationGnRH antagonist multiple dose protocol with oral contraceptive pill pretreatment in poor responders undergoing IVF/ICSI
ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2011.38.4.228 pissn 2233-8233 eissn 2233-8241 Clin Exp Reprod Med 2011;38(4):228-233 GnRH antagonist multiple dose protocol with oral contraceptive pill
More informationDipartimento di Neuroscienze, Scienze Riproduttive ed Odontostomatologiche. Tecniche di sincronizzazione ovocitaria. La sincronizzazione follicolare
Dipartimento di Neuroscienze, Scienze Riproduttive ed Odontostomatologiche Tecniche di sincronizzazione ovocitaria. La sincronizzazione follicolare Carlo Alviggi The rational of Follicular synchronization
More informationPrognostic factors of ovarian response and IVF outcome in patients with deep infiltrating endometriosis Claire GAUCHE-CAZALIS, Chadi YAZBECK
Prognostic factors of ovarian response and IVF outcome in patients with deep infiltrating endometriosis Claire GAUCHE-CAZALIS, Chadi YAZBECK Obstetrics Gynecology and Reproductive Medicine Department Bichat
More informationBody mass index and basal androstenedione are independent risk factors for miscarriage in polycystic ovary syndrome
Yang et al. Reproductive Biology and Endocrinology (2018) 16:119 https://doi.org/10.1186/s12958-018-0438-7 RESEARCH Open Access Body mass index and basal androstenedione are independent risk factors for
More informationIn Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome
Original Article Effect of Laparoscopic Ovarian Drilling on Outcomes of In Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome Maryam Eftekhar, M.D. 1, Razieh Deghani Firoozabadi,
More informationThe effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study
Clinical research The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study Ashraf Moini 1,2, Shahrzad Zadeh Modarress 3, Elham Amirchaghmaghi
More informationEndocrinology of the Female Reproductive Axis
Endocrinology of the Female Reproductive Axis girlontheriver.com Geralyn Lambert-Messerlian, PhD, FACB Professor Women and Infants Hospital Alpert Medical School at Brown University Women & Infants BROWN
More informationAnti-Mullerian Hormone as a Predictive Factor in Assisted Reproductive Technique of Polycystic Ovary Syndrome Patients
ORIGINAL REPORT Anti-Mullerian Hormone as a Predictive Factor in Assisted Reproductive Technique of Polycystic Ovary Syndrome Patients Ashraf Aleyasin, Marzie Aghahoseini, Sara Mokhtar, and Parvin Fallahi
More informationGottumukkala Achyuta Rama Raju S. C. Teng Prathigudupu Kavitha Balabomma Kavitha Lakshmi Cheemakurthi Ravikrishna
Reprod Med Biol (2012) 11:129 133 DOI 10.1007/s12522-012-0120-2 ORIGINAL ARTICLE Combination of recombinant follicle stimulating hormone with human menopausal gonadotrophin or recombinant luteinizing hormone
More informationOvarian hyperstimulation syndrome (OHSS)
Ovarian hyperstimulation syndrome (OHSS) OHSS OHSS: exaggerated response to gonadotropins and hcg Characterized by: ovarian enlargement increased vascular permeability fluid accumulation in abdomen Associated
More informationMODULE 1: OVULATION INDUCTION IN NORMAL RESPONDERS, POOR RESPONDERS, AND HYPERRESPONDERS
MODULE 1: OVULATION INDUCTION IN NORMAL RESPONDERS, POOR RESPONDERS, AND HYPERRESPONDERS Contents OVULATION INDUCTION IN NORMAL RESPONDERS, POOR RESPONDERS, AND HYPERRESPONDERS Ovulation Induction.....................................................................
More information